Clinical trial of hydroxychloroquine in Covid-19 patients paused: WHO


The World Health Organization said Monday that it had “temporarily” suspended clinical trials of hydroxychloroquine as a potential treatment for Covid-19 being carried out across a range of countries as a precautionary measure.

Photo: Reuters

A clinical trial of malaria drug hydroxychloroquine in COVID-19 patients has been suspended amid safety concerns, the World Health Organization (WHO) Director General Tedros Adhanom Ghebreyesus said on Monday.

“The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board. The other arms of the trial are continuing,” Tedros told an online briefing.

IndiaToday.in has plenty of useful resources that can help you better understand the coronavirus pandemic and protect yourself. Read our comprehensive guide (with information on how the virus spreads, precautions and symptoms), watch an expert debunk myths, and access our dedicated coronavirus page.
Get real-time alerts and all the news on your phone with the all-new India Today app. Download from

  • Andriod App
  • IOS App



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *